Aavantgarde Bio Ush1B study at Moorfields
Aavantgarde Bio Ush1B study at Moorfields
Search
Search results
Webinar: Getting active: sport and sight loss with British Blind Sport
Join us for our upcoming webinar!
Webinar: Getting active: sport and sight loss with British Blind Sport
The latest webinar from Retina UK.
AAVantgarde Completes Enrolment in Phase 1/2 Clinical Trial for Usher Syndrome Type B
The latest research news piece from Retina UK.
Clinical Trial Opportunity for Adults with Stargardt Disease
The clinical trial team at The Retina Clinic London have asked us to share an opportunity to participate in a Phase 1 clinical trial for AAVB 039 for Stargardt Disease.
Ocugen announce Phase 3 enrolment completion for OCU400, the largest gene agnostic therapy trial for RP
Biotechnology company Ocugen has announced the enrolment completion of their phase 3 clinical trial for OCU400.
Webinar: living well with inherited sight loss: a young adults perspective
Join our as our young adults share their lived experiences of navigating inherited sight loss.
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Meet a Researcher: Hajrah Sarkar
Hajrah Sarkar is a PhD student whose project is funded by Retina UK.
Meet a Researcher: Stéphanie Cornelis and Mubeen Khan
The project aims to develop a cost effective method of examining the entire ABCA4 gene to look for variations that might cause disease.